FOXE1 and neoplasm: The demonstration that variations in FOXE1 dosage change the tumour microenvironment suggests a previously unsuspected function for this transcription factor in addition to the well-established regulation of thyrocyte differentiation, indicating that FOXE1 could play a role more in thyroid cancer progression than in its onset.